New Delhi, June 22: Cipla, an Indian multinational pharmaceutical and biotechnology company, has launched its own 100 mg antiviral drug named Cipremi for treating severe COVID-19 patients. 'Cipremi', a drug for COVID-19 infection, has been approved for adult and
from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/3fLIZ83
This is dummy text. It is not meant to be read. Accordingly, it is difficult to figure out when to end it. But then, this is dummy text. It is not meant to be read. Period.
Related Post
Telangana: 18-year old girl's alleged abduction takes dramatic twist, marries 'kidnapper'Hyderabad, Dec 20: The alleged kidnap case of a 18-year-old woman by four people in a car in Rajann
Bharat Biotech's nasal vaccine to be rolled out as booster dose, likely to be available on Cowin by next weekNew Delhi, Dec 22: Amid a Covid-19 boom in China and several other countries, Bharat Biotech's
Indian Navy’s INSV Tarini to participate in 50th edition of Cape Town to Rio Race 2023New Delhi, Dec 19: Indian naval ship Tarini has set sail to Cape Town to participate in an ocean sa
Not just Joshimath, these tourist places in Uttarakhand that might sink in futureNew Delhi, Jan 13: Joshimath, a town in Uttarakhand's Chamoli district, which has more than 50 hote
ConversionConversion EmoticonEmoticon